Old Web
English
Sign In
Acemap
>
Paper
>
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
2021
Claudia Trojaniello
Maria Grazia Vitale
Paolo A. Ascierto
Keywords:
Asymptomatic
Medicine
Oncology
immune checkpoint inhibitors
Coronavirus disease 2019
Skin cancer
2019 20 coronavirus outbreak
Text mining
MEDLINE
in patient
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
7
References
1
Citations
NaN
KQI
[]